Nephrology
News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
News
Simple blood test may predict heart and kidney risk in T2D
“Three out of the four biomarkers are already clinically and commercially available,” while the fourth, for insulin-like growth factor binding...
News
Higher occurrence of kidney stones with more added sugar
Previous studies have shown the relationship between consuming sugar-sweetened beverages and a higher risk of obesity, diabetes, and...
News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
News from the FDA/CDC
FDA approves new drug, sotagliflozin, for heart failure
“It will be a reasonably tall task for sotagliflozin to come from behind and be disruptive in a space where there are already two well-established...
News
CKD Screening in all U.S. adults found cost effective
Modeling showed screening for and treating chronic kidney disease in U.S. adults was cost effective now that SGLT2 inhibitors are available.
News
SGLT2 inhibitors: Real-world data show benefits outweigh risks
“The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...
News
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
News
Fair access crucial for new diabetes/kidney disease drugs, say guidelines
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and...
News
Dapagliflozin reduces hospitalizations in patients with CKD
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.